Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis
Clinical trial NCT05570006 · COMPLETED
Trial details
- NCT number
- NCT05570006
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2024-12-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.